英文别名 |
Cabergoline;6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide;(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;FCE-21336;1-[(6-Allylergoline-8β-yl)carbonyl]-1-[3-(dimethylamino)-propyl]-3-ethylurea;Cabaser;Cabaseril;Cabergolina;Cabergolina [Spanish];Cabergolinum;Cabergolinum [Latin];Dostinex;Dostinex(R);Galastop;Galastop(R);N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-8g-ergoline-8-carboxamide;AB01275484-01;CABERGOLINE [JAN];N04BC06;UNII-LL60K9J05T;N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide;FCE-21336FCE-21336;CABERGOLINE [MI];FCE 21336;Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-;MS-28208;(8beta)-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide;6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide;MFCD00867887;HY-15296;1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea;HMS2090A09;CABERGOLINE [USP-RS];SR-05000001493-2;BIDD:GT0775;CABERGOLINE (USP-RS);BRD-K86882815-001-01-6;CG-101;DTXCID502719;Tox21_112589;Q423308;CABERGOLINE (USP MONOGRAPH);NCGC00167821-01;Cabaser (TN);Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-;Tox21_112589_1;BDBM50426497;Cabergoline (JAN/USP/INN);Cabergoline, European Pharmacopoeia (EP) Reference Standard;C08187;SCHEMBL42292;Caberlin;CHEBI:3286;CABERGOLINE [INN];Cabergoline (USAN:USP:INN:BAN);NS00001091;(8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide;(8beta)-N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-ergoline-8-carboxamide;CABERGOLINE [MART.];F17353;(6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide;GTPL37;CABERGOLINE (EP MONOGRAPH);SR-05000001493-1;(9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide;NCGC00344544-01;BRN 6020775;DB00248;1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea;(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide;1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea;Cabergoline, >=98% (HPLC);Sogilen;Dostinex (TN);ERGOLINE-8.BETA.-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-N-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-;Cabergoline; 1-Ethyl-3-[3-(dimethylamino)propyl]-3-[[(6aR,9R,10aR)-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]carbonyl]urea;EN300-19767804;1-[(6-Allylergo... |